David Schmidt

Bridging Science and Strategy into Scalable Growth

Oklahoma City, Oklahoma, United States

About

Biotech leader with nearly two decades of experience spanning diagnostics, biologics development, and CDMO services. I bring a unique combination of technical depth and commercial insight — having grown from hands-on analytical scientist to executive roles in business development and operations. My background includes analytical development, quality systems, and CMC strategy across the product lifecycle, but my true passion lies in building strong partnerships and helping clients navigate the complex path from discovery to commercialization. I thrive in fast-paced, high-growth environments and enjoy creating scalable systems that align technical excellence with business success. Currently serving as Sr. Director of Business Development at Joinn Biologics, I’m focused on helping innovators bring biologics to patients through agile, client-centered CDMO support.

Experience

  • Vice President of Business Development at GBI Bio
    Sep 2025 - Present · 11 mos

  • Sr. Director of Business Development at JOINN Biologics US Inc.
    May 2025 - Sep 2025 · 5 mos

  • Wheeler Bio, Inc. ()
    • Vice President of Business Operations
      Jun 2022 - Apr 2025 · 2 yrs 11 mos

    • Vice President of Analytics
      Oct 2020 - Jan 2023 · 2 yrs 4 mos

      Wheeler Bio is a new biomanufacturing company designed to accelerate the translation of therapeutic innovation into clinical impact. Through parallel integration with pre-clinical discovery, Wheeler is democratizing access to comprehensive discovery-to-IND programs with its rapid, high-quality biomanufacturing and portable CMC platform. With an initial focus on antibody therapeutics, the company is partnered with Alloy Therapeutics to offer emerging biopharma companies a faster and more predictable path to the clinic by avoiding the critical gaps between discovery and early development. Wheeler’s unique partnering model is built on shared success, creating a singular focus on quality, speed, and lasting collaborations. Wheeler Bio is headquartered in Oklahoma City with pilot labs located inside Alloy Therapeutics’ Boston, MA Facility.

  • Cytovance Biologics (10 yrs 8 mos)
    • Director of Analytical Development
      Dec 2016 - Oct 2020 · 3 yrs 11 mos

    • Supervisor of Analytical Development
      Mar 2012 - Oct 2020 · 8 yrs 8 mos

      Oversees the development and optimization of analytical methods for biopharmaceutical therapeutic products. Designs protocols to test methods transferred from clients to ensure they are ready for Quality Control. Oversee drafting of SOP's and Qualifications of analytical methods. Oversees all new method development. Draft development/optimization/transfer reports for analytical methods for client review. Discuss assay performance, resolution of issues, and assay timelines directly with clients. Transfers SOP's to Quality Control and oversees QC training and documentation. Oversees and reviews reports for all external testing for analytical procedures. Prepares lectures for Analytical Development and Quality Control on new products.

    • Quality Control Analyst
      Mar 2010 - Mar 2012 · 2 yrs 1 mo

      Performs analytical testing on biological recombinant proteins including release testing for Drug Substance and Drug Product for pre-clinical drug trials. Support for manufacturing with in process analytical testing, EM data trending, and OOS investigations with adherence to cGMP regulations. Other tasks include coordination of external testing, preparation of SOP's, preparation and performance of pre-clinical assay qualifications/validations, also preparation and performance of IQ, OQ, and PQ's on laboratory equipment.

  • Laboratory Tech at Excalibur Pathology
    Jul 2011 - Dec 2012 · 1 yr 6 mos

    Performed ocular histology on mice and rat for a contract pathology lab. Other tasked include paraffin embedding, microscopy, and H&E staining